alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Defense

###### Office of the Secretary

# AGENCY:

Department of Defense.

# ACTION:

Notice. 

# SUMMARY:

This Notice is published in accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463). The topic of the meeting on March 11-12, 2008 is to review new start and continuing research and development projects requesting Strategic Environmental Research and Development Program funds in excess of $1 M. This meeting is open to the public. Any interested person may attend, appear before, or file statements with the Scientific Advisory Board at the time and in the manner permitted by the Board.

# DATES:

Tuesday, March 11, 2008 from 9 a.m. to 4 p.m., Wednesday, March 12, 2008 from 9 a.m. to 3:30 p.m.

# ADDRESSES:

SERDP Program Office Conference Center, 901 North Stuart Street, Suite 804, Arlington, VA 22203.

# FOR FURTHER INFORMATION CONTACT:

Ms. Sharee Malcolm, SERDP Program Office, 901 North Stuart Street, Suite 303, Arlington, VA or by telephone at (703) 696-2119.

Dated: February 8, 2008.

L.M. Bynum, 

Alternate OSD Federal Register Liaison Officer, Department of Defense.

[FR Doc. 08-677 Filed 2-14-08; 8:45 am]

BILLING CODE 5001-06-M
I 

115TH CONGRESS 

2D SESSION H. R. 6087 

To authorize the Secretary of the Interior to recover the cost of processing 

administrative protests for oil and gas lease sales, applications for permits to drill, and right of way applications, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JUNE 13, 2018 

Ms. CHENEY (for herself, Mr. GIANFORTE, Mr. GOHMERT, Mr. BISHOP of 

Utah, and Mr. GOSAR) introduced the following bill; which was referred 

to the Committee on Natural Resources 

A BILL 

To authorize the Secretary of the Interior to recover the 

cost of processing administrative protests for oil and 

gas lease sales, applications for permits to drill, and 

right of way applications, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Removing Barriers to 

5 Energy Independence Act’’. 

6 SEC. 2. ADMINISTRATIVE PROTEST PROCESS REFORM. 

7 Section 17 of the Mineral Leasing Act (30 U.S.C. 

8 226) is amended by adding at the end the following: 


pamtmann on DSKBFK8HB2PROD with BILLS
2 

•HR 6087 IH

1 ‘‘(q) PROTEST FILING FEE.— 

2 ‘‘(1) IN GENERAL.—Before processing any pro3 test filed under this section, the Secretary shall col4 lect a filing fee from the protestor to recover the 

5 cost for processing documents filed for each adminis6 trative protest. 

7 ‘‘(2) AMOUNT.—The filing fee shall be cal8 culated as follows: 

9 ‘‘(A) For each protest filed in a submission 

10 not exceeding 10 pages in length, the base filing 

11 fee shall be $150. 

12 ‘‘(B) For each submission exceeding 10 

13 pages in length, an addition to the base filling 

14 fee, an assessment of $5 per page in excess of 

15 10 pages shall apply. 

16 ‘‘(C) For protests that include more than 

17 one oil and gas lease parcel, right-of-way, or ap18 plication for permit to drill in a submission, an 

19 additional assessment of $10 per additional 

20 lease parcel, right-of-way, or application for 

21 permit to drill shall apply. 

22 ‘‘(3) ADJUSTMENT.— 

23 ‘‘(A) IN GENERAL.—Beginning on January 

24 1, 2020, and annually thereafter, the Secretary 

25 shall adjust the filing fees established in this 


pamtmann on DSKBFK8HB2PROD with BILLS
3 

•HR 6087 IH

1 subsection to whole dollar amounts to reflect 

2 changes in the Producer Price Index, as pub3 lished by the Bureau of Labor Statistics, for 

4 the previous 12 months. 

5 ‘‘(B) PUBLICATION OF ADJUSTED FILING

6 FEES.—At least 30 days before the filling fees 

7 as adjusted under this paragraph take effect, 

8 the Secretary of the Interior shall publish noti9 fication of the adjustment of such fees in the 

10 Federal Register.’’. 

Æ 


pamtmann on DSKBFK8HB2PROD with BILLS
Exhibit
32.1


CERTIFICATION PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO




SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002




In
connection with the Quarterly Report of Universal Solar Technology, Inc. (the
"Company") on Form 10-Q for the quarter ended March 31, 2010 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I,
Wensheng Chen, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to
ss. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:




(1) The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and




(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





Date: May 17,
2010





/s/Wensheng
      ChenWensheng
      Chen, Principal Executive
                Officer
EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                                 18 U.S.C. 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of China Wi-Max Communications,  Inc. on
Form 10-Q for the period ended June 30, 2009, as filed with the  Securities  and
Exchange  Commission  on the date hereof (the  "Report"),  I, Frank R.  Ventura,
Chief Financial Officer of the Company,  certify, pursuant to 18 U.S.C. 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and

The  information  contained  in the  Report  fairly  presents,  in all  material
respects, the financial condition and results of operations of the Company.



Date: August 21, 2009



By:  /s/ Frank R. Ventura
     ----------------------------------
     Frank R. Ventura
     Chief Financial Officer
| 1.     | Such Quarterly Report of Form 10-Q/A for the period ending February 28, 2010, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                                                        |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |
| 2.     | The information contained in such Quarterly Report on Form 10-Q/A for the period ended February 28, 2010, fairly represents in all material respects, the financial condition and results of operations of Zhong Sen International Tea Company. |

| Date:  May 23, 2011             |
|-------------------------------------------|
|                                      |
| Zhong Sen International Tea Company       |
|                                      |
| By: /s/ Binquan Zhang                |
| Binquan ZhangChief Financial Officer |
Exhibit 10.1


 


ACTINIUM PHARMACEUTICALS, INC.


 


SECOND AMENDMENT TO THE

AMENDED AND RESTATED 2013 STOCK PLAN


 


WHEREAS, Actinium Pharmaceuticals,
Inc. (the “Company”) maintains the Actinium Pharmaceuticals, Inc. Amended and Restated 2013 Stock Plan, as amended
(the “Plan”) to provide for certain equity incentive compensation awards to employees, directors and consultants
of the Company; and


 


WHEREAS, the Board of Directors
of the Company has determined that it is in the best interests of the Company to amend the Plan to not permit repricing or the
exchange of options granted under the Plan by the Board of Directors (the “Board”), or a committee of the Board, to
a lower exercise price.


 


NOW, THEREFORE, the Company
does hereby amend the Plan, effective December 15, 2015, as follows:


 


		1.	Section 2(v) (Definitions) of the Plan is hereby amended to read
in its entirety as follows:
	 	 	 
	 	 	“(v) Intentionally omitted.”
	 	 	 
		2.	Section 3 (Stock Subject to the Plan) of the Plan is hereby amended by revising the second sentence
thereof to read in its entirety as follows:
	 	 	 
			“If an award should expire or become unexercisable for any reason without
having been exercised in full, the unpurchased Shares that were subject thereto shall, unless the Plan shall have been terminated,
become available for future grant under the Plan.”
	 	 	 
		3.	Section 4(c)(viii) (Powers of the Administrator) of the Plan is hereby amended
to read in its entirety as follows:
	 	 	 
	 	 	“(viii) Intentionally omitted.”
	 	 	 
	 	4.	Except as explicitly set forth herein, the Plan will remain in full force and effect.




IN WITNESS WHEREOF, the Company
has caused this amendment to the Plan to be executed as of the effective date set forth above by its duly authorized officer.


 





		ACTINIUM PHARMACEUTICALS, INC.
	 	 	 
	 	/s/ Kaushik J. Dave
	 	Name:	Kaushik J. Dave
	 	Title:	Chief Executive Officer
Division of Compensation Analysis and 

Support

Program Evaluation Report

Document Number: DCAS-PER-076

Effective Date: 2/15/2017

Revision No. 0

Aliquippa Forge TBD Page 1 of 2

Author: Signature on file Date: 2/15/2017 Dave Allen, HP Team Leader

Approval: Signature on file Date: 2/15/2017 

 J.W. Neton, Associate Director for Science

Supersedes: None

RECORD OF ISSUE/REVISIONS

ISSUE 

AUTHORIZATION 

DATE

2/15/2017

EFFECTIVE 

DATE

2/15/2017

REV. NO. 

0

DESCRIPTION

New document to determine the effect of 

the revision to ORAUT-TKBS-0021, 

(Aliquippa Forge) on previously 

completed claims.

1.0 Description

Dose reconstructions for the claims from the Aliquippa Forge site have been performed 

using a TBD (ORAUT-TKBS-0021) originally issued on 12/21/2004. The document was 

revised on 4/26/2012. DCAS-PER-045 was issued on 5/13/2013 evaluating the effect of 

that revision on previously completed claims. A new revision (revision 2) of the TBD 

was issued was issued on 11/16/2015. This PER (DCAS-PER-076) evaluates the effect 

of revision 2 of the TBD on all previously completed claims.

2.0 Issue Evaluation

The change in revision 2 of the TBD was based on a reevaluation of air sample data near 

the end of the operational period. Because of this reevaluation, the internal and external 

doses in the residual period (1950 through 1995) increased for all years. The revision did 

not change the internal or external operational period doses. The change therefore 

resulted in increased doses for all claims completed using an earlier version of the TBD 

that had employment during the residual period. 

3.0 Plan for Resolution or Corrective Action

To evaluate the effect of revision 2 of the TBD on all previously completed claims, a 

search was conducted for all completed claims with verified employment at Aliquippa 

Forge that had a probability of causation (POC) of less than 50%. This search identified 

26 claims. Five of these claims had employment only during the operational period and 
Division of Compensation Analysis and 

Support

Program Evaluation Plan

Document Number: DCAS-PER-076

Effective Date: 2/15/2017 Revision No. 0 Page 2 of 2

so the revision would not affect the calculated dose. Those five were removed from 

further evaluation.

A new dose estimate was performed for the remaining 21 claims using revision 2 of the 

TBD, as well as all other applicable approved dose reconstruction methods. The 

resulting probability of causation (POC) was below 45% for 20 claims. The one 

remaining claim resulted in a POC greater than 52%. 

NIOSH will provide the Department of Labor with the list of all claims evaluated under 

this PER and request the return of the one claim that would now result in a POC greater 

than 50%.
# Sheet
IN THE SUPREME COURT OF PENNSYLVANIA

EASTERN DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

PEDRO SILVA,

Petitioner

:

:

:

:

:

:

:

:

:

:

:

No. 309 EAL 2018

Petition for Allowance of Appeal from 

the Order of the Superior Court

ORDER

PER CURIAM

AND NOW, this 18th day of December, 2018, the Petition for Allowance of Appeal

is DENIED.
IN THE SUPREME COURT OF PENNSYLVANIA

WESTERN DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

MARK A. HUNTER,

Petitioner

:

:

:

:

:

:

:

:

:

:

:

No. 401 WAL 2019

Petition for Allowance of Appeal 

from the Order of the Superior Court

ORDER

PER CURIAM

AND NOW, this 30th day of March, 2020, the Petition for Allowance of Appeal is 

DENIED.
<TABLE> <S> <C>

<ARTICLE> BD
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                          24,647
<RECEIVABLES>                                  103,568
<SECURITIES-RESALE>                             41,250
<SECURITIES-BORROWED>                                0
<INSTRUMENTS-OWNED>                            414,245
<PP&E>                                          24,644
<TOTAL-ASSETS>                                 818,003
<SHORT-TERM>                                         0
<PAYABLES>                                     239,475
<REPOS-SOLD>                                    10,983
<SECURITIES-LOANED>                                  0
<INSTRUMENTS-SOLD>                             234,026
<LONG-TERM>                                     61,303
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           218
<OTHER-SE>                                     271,998
<TOTAL-LIABILITY-AND-EQUITY>                   818,003
<TRADING-REVENUE>                              146,638
<INTEREST-DIVIDENDS>                            66,228
<COMMISSIONS>                                  228,198
<INVESTMENT-BANKING-REVENUES>                   72,852
<FEE-REVENUE>                                   67,106
<INTEREST-EXPENSE>                              38,145
<COMPENSATION>                                 362,239
<INCOME-PRETAX>                                 47,985
<INCOME-PRE-EXTRAORDINARY>                      29,117
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    29,117
<EPS-BASIC>                                       1.45
<EPS-DILUTED>                                     1.39


</TABLE>
Exhibit
32.1




CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





I, Ronald
Williams, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report
on Form 10-Q of DRC Ventures, Inc. for the quarter ended September 30, 2010
fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934 and that information contained in such
Quarterly Report on Form 10-Q fairly presents in all material respects the
financial condition and results of operations of DRC Ventures, Inc.





Dated:
      November 16, 2010
              By:
              /s/ Ronald WilliamsName:
              Ronald
      WilliamsTitle:
              President,
      Principal Executive Officer
                and
      Principal Financial Officer





The
foregoing certification is being furnished solely pursuant to 18 U.S.C. Section
1350 and is not being filed as part of the Report or as a separate disclosure
document.
[Federal Register Volume 73, Number 42 (Monday, March 3, 2008)]
[Notices]
[Pages 11467-11468]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-910]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Genomic Medicine Program Advisory Committee; Notice of Renewal

    The Department of Veterans Affairs (VA) gives notice that the 
Genomic Medicine Program Advisory Committee has been renewed for a two 
year period.
    The Committee provides advice to the Secretary of Veterans Affairs 
on the scientific and ethical issues related to the development and 
operation of VA's genomic medicine program. The Committee is guided by 
the goal of

[[Page 11468]]

using genetic information to optimize clinical care of veterans and to 
enhance the study and development of diagnostic tests and treatments 
for diseases of particular relevance to veterans.

    Dated: February 22, 2008.

    By Direction of the Secretary.
E. Philip Riggin,
Committee Management Officer.
[FR Doc. 08-910 Filed 2-29-08; 8:45 am]
BILLING CODE 8320-01-M
May 22, 2014


 


Ohio
State Innovation Foundation Attn:
 Timothy R.
Wright,
President 1524 North
High Street


Columbus,
Ohio  43201


 


Re:License
Agreements/Upfront Fees


 


 


Dear Mr.Wright:


 


Reference
is made to
(1 ) the
Patent & Technology
License Agreement, Agt.
No. A2014-0165, entered into
as of September
6, 2013, by
and between Microlin Bio,
Inc. ("Microlin") and
Ohio State Innovation Foundation ("OSIF'),
as amended, (2) the
Patent & Technology
License Agreement, Agt. No. A2013- 2080,
entered into as of September
6, 2013, by and between Microlin
and OSIF, as amended, (3) the Patent
& Technology License Agreement, Agt.
No. A2013-2069, entered into as
of September 6, 2013, by and between
Microlin and OSIF, as amended, (4)
the Patent & Technology
License Agreement, Agt. No.A2014-0164, entered into as
of September 6, 2013,
by and between Microlin and OSIF, as
amended, and (5) the Patent &
Technology License Agreement. Agt.
No.A2014-0294, entered into as
of September 6, 2013, by and between Microlin
and OSIF, as amended (collectively, the
"Agreements ").


 


Each
of the Agreements
provide that Microlin
is to pay an
upfront fee to OSIF
on or before
May 31, 2014 for
the patents licensed from OSIF under the
Agreements. The upfront fees
payable to OSIF on or
before May 31, 2014
total $500,000 in the aggregate
(the "May 2014 Fee").


 


This
letter serves to
confirm our agreement
regarding
Microlin's
obligations
with respect to
the May 2014
Fee. Mkrolin acknowledges that
it owes OSIF $500,000
on or before May 31,
2014 pursuant to the Agreements
and OSIF agrees to defer
Microlin's obligation to pay
such amount on or before May 31,
2014 as set
forth below. Microlin and OSIF agree
that the May 2014 Fee
will be paid in full from Microlin
to OSIF via wire transfer
no later than
three (3) calendar days after the
day on which Microlin delivers
its registered securities to its underwriter(s) and receives payment for these
securities (the "Closing Date").
In the event that
the Closing Date does
not occur or occurs after
June 30, 2014, the parties will
agree to a commercially reasonable alternati ve payment
schedule.


 


 


		
        Sincerely,

         

         

        /s/ Joseph Hernandez

        Joseph Hernandez

        Executive Chairman



 


 


[Acknowledgement
page follows]




    	 	 	 



     


    

ACKNOWLEDGED AND AGREED TO BY:


 


OHIO STATE INNOVATJON FOUNDATION


 


By: /s/ Erin Bender


Name: Erin Bender


Title: Vice President








    	 	2
INVESCO BOND FUNDS, INC.
                            ------------------------

                            CERTIFICATE OF CORRECTION

THIS IS TO CERTIFY THAT:

     FIRST:  The title of the  document  being  corrected  hereby is Articles of
Amendment (the "Articles").

     SECOND:  The Articles were filed with the State  Department of  Assessments
and Taxation of Maryland ("SDAT") on August 13, 1999.

     THIRD:  The only party to the  Articles  is INVESCO  Bond  Funds,  Inc.,  a
Maryland  corporation,  registered as an open-end  company under the  Investment
Company Act of 1940 (the "Corporation").

     FOURTH: The Articles were defectively executed, as the Articles were signed
and  acknowledged by an officer who is not permitted to do so under the Maryland
General Corporation Law.

     The undersigned President acknowledges this Certificate of Correction to be
the corporate  act of the  Corporation  and further,  as to all matters or facts
required to be verified under oath, the undersigned President acknowledges, that
to the best of his knowledge,  information and belief, the matters and facts set
forth herein are true in all material  respects and that this  statement is made
under the penalties for perjury.



                           [SIGNATURE PAGE FOLLOWS]
<PAGE>


            IN WITNESS WHEREOF, the Corporation has caused this Certificate
of Correction to be signed in its name and on its behalf by the officers
below on this 25th day of January, 2002.



ATTEST:                                INVESCO BOND FUNDS, INC.


/s/ Glen A. Payne                      By: /s/ Raymond R. Cunningham
_________________                          _________________________
Glen A. Payne                              Raymond R. Cunningham
Secretary                                  Vice President
Exhibit 8.1

                              COUNTRY OF              OWNERSHIP       VESSEL
NAME                          INCORPORATION           INTEREST        OWNED

New Subsidiaries:
KTL Camden, Inc.              Republic of Liberia      100%           Camden
KTL Chelsea, Inc.             Republic of Liberia      100%           Chelsea
KTL Kensington, Inc.          Republic of Liberia      100%           TI Qingdao
KTL Hampstead, Inc.           Republic of Liberia      100%           TI Ningbo
KTL Mayfair, Inc.             Republic of Liberia      100%           Mayfair

Original Subsidiaries:
Cedarhurst Tankers LDC        Cayman Islands           100%           -
Hewlett Tankers LDC           Cayman Islands           100%           -
Inwood Tankers LDC            Cayman Islands           100%           -
Lawrence Tankers LDC          Cayman Islands           100%           -
Woodmere Tankers LDC          Cayman Islands           100%           -